Brought to you by 
Pacira Pharmaceuticals nets $39.1mm through its IPO
14 Nov 2011
Executive Summary
Pacira Pharmaceuticals Inc. (injectable acute care therapeutics) has netted $39mm through the initial public offering of 6mm common shares at $7 each. Just last month the company planned to sell 4.25mm shares between $14-16 apiece.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
-
Biotechnology
- Liposomes
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pacira Pharmaceuticals nets $39.1mm through its IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice